457 related articles for article (PubMed ID: 10607834)
1. Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1.
Ars E; Serra E; García J; Kruyer H; Gaona A; Lázaro C; Estivill X
Hum Mol Genet; 2000 Jan; 9(2):237-47. PubMed ID: 10607834
[TBL] [Abstract][Full Text] [Related]
2. Recurrent mutations in the NF1 gene are common among neurofibromatosis type 1 patients.
Ars E; Kruyer H; Morell M; Pros E; Serra E; Ravella A; Estivill X; Lázaro C
J Med Genet; 2003 Jun; 40(6):e82. PubMed ID: 12807981
[No Abstract] [Full Text] [Related]
3. Identification and characterization of NF1 splicing mutations in Korean patients with neurofibromatosis type 1.
Jang MA; Kim YE; Kim SK; Lee MK; Kim JW; Ki CS
J Hum Genet; 2016 Aug; 61(8):705-9. PubMed ID: 27074763
[TBL] [Abstract][Full Text] [Related]
4. Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects.
Messiaen LM; Callens T; Mortier G; Beysen D; Vandenbroucke I; Van Roy N; Speleman F; Paepe AD
Hum Mutat; 2000; 15(6):541-55. PubMed ID: 10862084
[TBL] [Abstract][Full Text] [Related]
5. NF1 mutations in neurofibromatosis 1 patients with plexiform neurofibromas.
Kluwe L; Friedrich RE; Korf B; Fahsold R; Mautner VF
Hum Mutat; 2002 Mar; 19(3):309. PubMed ID: 11857752
[TBL] [Abstract][Full Text] [Related]
6. Somatic NF1 mutational spectrum in benign neurofibromas: mRNA splice defects are common among point mutations.
Serra E; Ars E; Ravella A; Sánchez A; Puig S; Rosenbaum T; Estivill X; Lázaro C
Hum Genet; 2001 May; 108(5):416-29. PubMed ID: 11409870
[TBL] [Abstract][Full Text] [Related]
7. NF1 mutation rather than individual genetic variability is the main determinant of the NF1-transcriptional profile of mutations affecting splicing.
Pros E; Larriba S; López E; Ravella A; Gili ML; Kruyer H; Valls J; Serra E; Lázaro C
Hum Mutat; 2006 Nov; 27(11):1104-14. PubMed ID: 16937374
[TBL] [Abstract][Full Text] [Related]
8. NF1 molecular characterization and neurofibromatosis type I genotype-phenotype correlation: the French experience.
Sabbagh A; Pasmant E; Imbard A; Luscan A; Soares M; Blanché H; Laurendeau I; Ferkal S; Vidaud M; Pinson S; Bellanné-Chantelot C; Vidaud D; Parfait B; Wolkenstein P
Hum Mutat; 2013 Nov; 34(11):1510-8. PubMed ID: 23913538
[TBL] [Abstract][Full Text] [Related]
9. Two independent mutations in a family with neurofibromatosis type 1 (NF1).
Klose A; Peters H; Hoffmeyer S; Buske A; Lüder A; Hess D; Lehmann R; Nürnberg P; Tinschert S
Am J Med Genet; 1999 Mar; 83(1):6-12. PubMed ID: 10076878
[TBL] [Abstract][Full Text] [Related]
10. Neurofibromatosis Type 1 and tumorigenesis: molecular mechanisms and therapeutic implications.
Gottfried ON; Viskochil DH; Couldwell WT
Neurosurg Focus; 2010 Jan; 28(1):E8. PubMed ID: 20043723
[TBL] [Abstract][Full Text] [Related]
11. Illegitimate splicing of the NF1 gene in healthy individuals mimics mutation-induced splicing alterations in NF1 patients.
Wimmer K; Eckart M; Rehder H; Fonatsch C
Hum Genet; 2000 Mar; 106(3):311-3. PubMed ID: 10798360
[TBL] [Abstract][Full Text] [Related]
12. Non-coding RNA ANRIL and the number of plexiform neurofibromas in patients with NF1 microdeletions.
Mußotter T; Kluwe L; Högel J; Nguyen R; Cooper DN; Mautner VF; Kehrer-Sawatzki H
BMC Med Genet; 2012 Oct; 13():98. PubMed ID: 23101500
[TBL] [Abstract][Full Text] [Related]
13. Non-Coding RNA and Tumor Development in Neurofibromatosis Type 1:
Tritto V; Ferrari L; Esposito S; Zuccotti P; Bianchessi D; Natacci F; Saletti V; Eoli M; Riva P
Genes (Basel); 2019 Nov; 10(11):. PubMed ID: 31694342
[TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of sporadic and inherited mutations in exon 31 of the neurofibromatosis (NF1) gene.
Ainsworth PJ; Rodenhiser DI; Costa MT
Hum Genet; 1993 Mar; 91(2):151-6. PubMed ID: 8385067
[TBL] [Abstract][Full Text] [Related]
15. Extensive in silico analysis of NF1 splicing defects uncovers determinants for splicing outcome upon 5' splice-site disruption.
Wimmer K; Roca X; Beiglböck H; Callens T; Etzler J; Rao AR; Krainer AR; Fonatsch C; Messiaen L
Hum Mutat; 2007 Jun; 28(6):599-612. PubMed ID: 17311297
[TBL] [Abstract][Full Text] [Related]
16. Neurofibromatosis type 1 (NF1): a protein truncation assay yielding identification of mutations in 73% of patients.
Park VM; Pivnick EK
J Med Genet; 1998 Oct; 35(10):813-20. PubMed ID: 9783703
[TBL] [Abstract][Full Text] [Related]
17. The mutational spectrum of the NF1 gene in neurofibromatosis type I patients from UAE.
Ben-Salem S; Al-Shamsi AM; Ali BR; Al-Gazali L
Childs Nerv Syst; 2014 Jul; 30(7):1183-9. PubMed ID: 24413922
[TBL] [Abstract][Full Text] [Related]
18. Characterization of NF1 allele containing two nonsense mutations in exon 37 that segregates with neurofibromatosis type 1.
Hernández-Imaz E; Campos B; Rodríguez-Álvarez FJ; Abad O; Melean G; Gardenyes J; Martín Y; Hernández-Chico C
Clin Genet; 2013 May; 83(5):462-6. PubMed ID: 22925204
[TBL] [Abstract][Full Text] [Related]
19. A novel mutation in the NF1 gene in two siblings with neurofibromatosis type 1 and bilateral optic pathway glioma.
Kebudi R; Tuncer S; Upadhyaya M; Peksayar G; Spurlock G; Yazici H
Pediatr Blood Cancer; 2008 Mar; 50(3):713-5. PubMed ID: 17514731
[TBL] [Abstract][Full Text] [Related]
20. Molecular diagnosis of neurofibromatosis type 1: 2 years experience.
Griffiths S; Thompson P; Frayling I; Upadhyaya M
Fam Cancer; 2007; 6(1):21-34. PubMed ID: 16944272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
